5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool expansion in cultured L1210 cells treated with inhibitors of thymidylate synthase
Ling-Wa Chong, Martin H.N. Tattersall · Biochemical Pharmacology · 1995
Cited by 15 works. doi:10.1016/0006-2952(94)00458-x
Authors
References
- Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.
- ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
- Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.
- A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis
- The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis.
- The cellular pharmacology of methotrexate
- Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death.
- The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells
- Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase